Home
ILMN
ILMN News

Latest Illumina Inc. (ILMN) News on October 10, 2025

ILMN Stock Set to Benefit From the Launch of New BioInsight Division

Zacks

7 days ago

ILMN Stock Set to Benefit From the Launch of New BioInsight Division

Why Illumina (ILMN) Shares Are Falling Today

StockStory

7 days ago

Why Illumina (ILMN) Shares Are Falling Today

Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker

Zacks

8 days ago

Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker

Illumina (ILMN) Expands TruSight Oncology Test With New KRAS CDx Collaborations

Insider Monkey

8 days ago

Illumina (ILMN) Expands TruSight Oncology Test With New KRAS CDx Collaborations

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

Business Wire

8 days ago

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

Why Is Illumina (ILMN) Stock Rocketing Higher Today

StockStory

8 days ago

Why Is Illumina (ILMN) Stock Rocketing Higher Today

MT Newswires

9 days ago

Illumina Launches New Business to Develop Data Assets, Software for Drug Development

Illumina launches new business to accelerate technology and data-driven discovery

PR Newswire

9 days ago

Illumina launches new business to accelerate technology and data-driven discovery

Illumina advances personalized cancer care with new pharma development partnerships

PR Newswire

17 days ago

Illumina advances personalized cancer care with new pharma development partnerships

Brown Advisory Global Leaders Strategy Exited Illumina (ILMN) in Q2. Here’s Why

Insider Monkey

18 days ago

Brown Advisory Global Leaders Strategy Exited Illumina (ILMN) in Q2. Here’s Why

Does Alnylam's Entry Into the Genomics Alliance Hint at a New Era for Illumina (ILMN) R&D?

Simply Wall St.

20 days ago

Does Alnylam's Entry Into the Genomics Alliance Hint at a New Era for Illumina (ILMN) R&D?

3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025

Zacks

22 days ago

3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025

MT Newswires

22 days ago

Alnylam Joins Alliance for Genomic Discovery

Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine

PR Newswire

22 days ago

Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine

US NGS Market Forecast and Company Analysis Report 2025-2033: Illumina, Thermo Fisher Scientific, Pacific Biosciences, QIAGEN, Roche, Bio-Rad Laboratories, Takara Bio, Hamilton, Geneious, BioMerieux

GlobeNewswire

22 days ago

US NGS Market Forecast and Company Analysis Report 2025-2033: Illumina, Thermo Fisher Scientific, Pacific Biosciences, QIAGEN, Roche, Bio-Rad Laboratories, Takara Bio, Hamilton, Geneious, BioMerieux

GRAIL, Inc. (GRAL): A Bull Case Theory

Insider Monkey

24 days ago

GRAIL, Inc. (GRAL): A Bull Case Theory

Why Illumina (ILMN) Stock Is Falling Today

StockStory

a month ago

Why Illumina (ILMN) Stock Is Falling Today

Argus Research

a month ago

Weekly Stock List

Illumina (ILMN): Buy, Sell, or Hold Post Q2 Earnings?

StockStory

a month ago

Illumina (ILMN): Buy, Sell, or Hold Post Q2 Earnings?

CRISPR Therapeutics (CRSP) Down 5.3% Since Last Earnings Report: Can It Rebound?

Zacks

a month ago

CRISPR Therapeutics (CRSP) Down 5.3% Since Last Earnings Report: Can It Rebound?

Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development

PR Newswire

a month ago

Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development

MicroGenDX's New Testing Platform Cuts NGS Turnaround Time to 24 Hours for Life-Saving Decisions

ACCESS Newswire

a month ago

MicroGenDX's New Testing Platform Cuts NGS Turnaround Time to 24 Hours for Life-Saving Decisions

Illumina (ILMN) Outpaces Expectations Despite Revenue Dip Could Be a Game Changer for Growth Narrative

Simply Wall St.

a month ago

Illumina (ILMN) Outpaces Expectations Despite Revenue Dip Could Be a Game Changer for Growth Narrative

Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others

GlobeNewswire

a month ago

Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others

Life Sciences Tools & Services Stocks Q2 Results: Benchmarking Illumina (NASDAQ:ILMN)

StockStory

a month ago

Life Sciences Tools & Services Stocks Q2 Results: Benchmarking Illumina (NASDAQ:ILMN)

DNA Forensics Market Analysis Report 2025 | Market Revenue Data from 2022 to 2024, Estimates for 2025, and Projected CAGRs Through 2030

GlobeNewswire

a month ago

DNA Forensics Market Analysis Report 2025 | Market Revenue Data from 2022 to 2024, Estimates for 2025, and Projected CAGRs Through 2030

AdaptHealth, Illumina, Globalstar, Iridium, and Alight Shares Are Soaring, What You Need To Know

StockStory

2 months ago

AdaptHealth, Illumina, Globalstar, Iridium, and Alight Shares Are Soaring, What You Need To Know

Nilesh Shah joins Illumina as Head of Region, AMEA

PR Newswire

2 months ago

Nilesh Shah joins Illumina as Head of Region, AMEA

Cathie Wood's Bold AI and Genomics Playbooks Revealed

GuruFocus.com

3 months ago

Cathie Wood's Bold AI and Genomics Playbooks Revealed

Cathie Wood Pours Millions into Nvidia and Biotech, Dumps Rocket Lab

GuruFocus.com

3 months ago

Cathie Wood Pours Millions into Nvidia and Biotech, Dumps Rocket Lab

Clinical Next Generation Sequencing Market Trends and Forecasts Report 2025-2032 | Personalized Medicine and R&D Investments Propel Growth

GlobeNewswire

3 months ago

Clinical Next Generation Sequencing Market Trends and Forecasts Report 2025-2032 | Personalized Medicine and R&D Investments Propel Growth

Proteomic Biomarker Analytics Market Forecast Report 2025: Proteomics Steps Up Where Genomics Falls Short

GlobeNewswire

3 months ago

Proteomic Biomarker Analytics Market Forecast Report 2025: Proteomics Steps Up Where Genomics Falls Short

Illumina Stock May Benefit From New Agreement to Acquire SomaLogic

Zacks

3 months ago

Illumina Stock May Benefit From New Agreement to Acquire SomaLogic

Avance Biosciences Launches NGS Center of Excellence in Houston

PR Newswire

3 months ago

Avance Biosciences Launches NGS Center of Excellence in Houston

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

PR Newswire

4 months ago

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

Illumina, Inc. (ILMN): A Bull Case Theory

Insider Monkey

4 months ago

Illumina, Inc. (ILMN): A Bull Case Theory

Insider Stock Buying Reaches US$1.49m On Illumina

Simply Wall St.

4 months ago

Insider Stock Buying Reaches US$1.49m On Illumina

Illumina bets on proteomics with $425m SomaLogic purchase

Medical Device Network

4 months ago

Illumina bets on proteomics with $425m SomaLogic purchase

MT Newswires

4 months ago

Illumina Signs Deal With Standard BioTools to Acquire SomaLogic

PR Newswire

4 months ago

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina

GlobeNewswire

4 months ago

Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina

Illumina to buy SomaLogic for up to $425M

MedTech Dive

4 months ago

Illumina to buy SomaLogic for up to $425M

Canaccord Raises Price Target Of Illumina, Inc. (ILMN).

Insider Monkey

4 months ago

Canaccord Raises Price Target Of Illumina, Inc. (ILMN).

FTRE vs. ILMN: Which Stock Should Value Investors Buy Now?

Zacks

4 months ago

FTRE vs. ILMN: Which Stock Should Value Investors Buy Now?

1 of Wall Street’s Favorite Stock to Target This Week and 2 to Brush Off

StockStory

4 months ago

1 of Wall Street’s Favorite Stock to Target This Week and 2 to Brush Off

3 Reasons ILMN is Risky and 1 Stock to Buy Instead

StockStory

4 months ago

3 Reasons ILMN is Risky and 1 Stock to Buy Instead

Incyte Stock Rises on QIAGEN Deal to Advance Blood Cancer Diagnostics

Zacks

4 months ago

Incyte Stock Rises on QIAGEN Deal to Advance Blood Cancer Diagnostics

Argus Research

4 months ago

Analyst Report: Illumina Inc

Argus Research

4 months ago

Market Digest: ILMN, CAT, BBWI, WBD

3 Mid-Cap Stocks Walking a Fine Line

StockStory

4 months ago

3 Mid-Cap Stocks Walking a Fine Line

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

PR Newswire

4 months ago

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

ILMN Q1 Earnings Call: Clinical Growth and Cost Actions Offset Research and China Headwinds

StockStory

4 months ago

ILMN Q1 Earnings Call: Clinical Growth and Cost Actions Offset Research and China Headwinds

Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain?

Zacks

4 months ago

Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain?

Illumina, Inc. (ILMN) Unveils AI Breakthrough for Rare Disease Diagnosis

Insider Monkey

4 months ago

Illumina, Inc. (ILMN) Unveils AI Breakthrough for Rare Disease Diagnosis

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis

PR Newswire

4 months ago

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis

Illumina widens access to cancer tests with Medicare and new CDx

Medical Device Network

4 months ago

Illumina widens access to cancer tests with Medicare and new CDx

Stifel Affirms Buy Rating on Illumina (ILMN) Stock

Insider Monkey

4 months ago

Stifel Affirms Buy Rating on Illumina (ILMN) Stock

Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies

PR Newswire

4 months ago

Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies

Illumina's TSO Comprehensive Earns Japan's Approval: Stock to Gain?

Zacks

4 months ago

Illumina's TSO Comprehensive Earns Japan's Approval: Stock to Gain?

Life Sciences Tools & Services Stocks Q1 Recap: Benchmarking Illumina (NASDAQ:ILMN)

StockStory

4 months ago

Life Sciences Tools & Services Stocks Q1 Recap: Benchmarking Illumina (NASDAQ:ILMN)

Danaher, Illumina, Globalstar, and Insperity Shares Plummet, What You Need To Know

StockStory

5 months ago

Danaher, Illumina, Globalstar, and Insperity Shares Plummet, What You Need To Know

Illumina Stock to Gain From the Launch of New DRAGEN v4.4 Software

Zacks

5 months ago

Illumina Stock to Gain From the Launch of New DRAGEN v4.4 Software

Argus Research

5 months ago

Daily – Vickers Top Buyers & Sellers for 05/15/2025

Illumina To Webcast Upcoming Investor Conference

PR Newswire

5 months ago

Illumina To Webcast Upcoming Investor Conference

MT Newswires

5 months ago

UBS Adjusts Price Target on Illumina to $98 From $145, Maintains Neutral Rating

Illumina First Quarter 2025 Earnings: EPS Beats Expectations

Simply Wall St.

5 months ago

Illumina First Quarter 2025 Earnings: EPS Beats Expectations

Illumina, Inc. (ILMN): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying

Insider Monkey

5 months ago

Illumina, Inc. (ILMN): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying

Investing in Illumina (ILMN)? Don't Miss Assessing Its International Revenue Trends

Zacks

5 months ago

Investing in Illumina (ILMN)? Don't Miss Assessing Its International Revenue Trends

Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications

PR Newswire

5 months ago

Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications

Illumina, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Simply Wall St.

5 months ago

Illumina, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

3 Volatile Stocks with Mounting Challenges

StockStory

5 months ago

3 Volatile Stocks with Mounting Challenges

MT Newswires

5 months ago

Illumina Faces Uncertainties From China Ban, Research Slump, Morgan Stanley Says

MT Newswires

5 months ago

Morgan Stanley Adjusts Illumina Price Target to $100 From $136, Maintains In Line Rating

Illumina price target lowered to $135 from $160 at Stifel

TipRanks

5 months ago

Illumina price target lowered to $135 from $160 at Stifel

SEC ends probe of Illumina’s Grail acquisition

MedTech Dive

5 months ago

SEC ends probe of Illumina’s Grail acquisition

Thomson Reuters StreetEvents

5 months ago

Q1 2025 Illumina Inc Earnings Call

Illumina Q1 Earnings Top Estimates, Revenues Down Y/Y, Stock Dips

Zacks

5 months ago

Illumina Q1 Earnings Top Estimates, Revenues Down Y/Y, Stock Dips

GuruFocus.com

5 months ago

Illumina Inc (ILMN) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...

Illumina (ILMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

5 months ago

Illumina (ILMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Morningstar Research

5 months ago

Analyst Report: Illumina, Inc.

Illumina (ILMN) Tops Q1 Earnings and Revenue Estimates

Zacks

5 months ago

Illumina (ILMN) Tops Q1 Earnings and Revenue Estimates

Illumina’s (NASDAQ:ILMN) Q1 Sales Top Estimates

StockStory

5 months ago

Illumina’s (NASDAQ:ILMN) Q1 Sales Top Estimates

MT Newswires

5 months ago

Illumina Q1 Non-GAAP Earnings, Revenue Decline; Reduces Full Year Guidance

Associated Press Finance

5 months ago

Illumina: Q1 Earnings Snapshot

Thomson Reuters StreetEvents

5 months ago

Q1 2025 Standard BioTools Inc Earnings Call

Here’s Why Artisan Mid Cap Fund Decided to Exit Illumina (ILMN)

Insider Monkey

5 months ago

Here’s Why Artisan Mid Cap Fund Decided to Exit Illumina (ILMN)

Earnings To Watch: Illumina (ILMN) Reports Q1 Results Tomorrow

StockStory

5 months ago

Earnings To Watch: Illumina (ILMN) Reports Q1 Results Tomorrow

Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks

5 months ago

Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Unveiling Illumina (ILMN) Q1 Outlook: Wall Street Estimates for Key Metrics

Zacks

5 months ago

Unveiling Illumina (ILMN) Q1 Outlook: Wall Street Estimates for Key Metrics

MT Newswires

5 months ago

Illumina Partners With Ovation.io to Create GLP-1 Dataset for Drug Discovery

Illumina (ILMN) Earnings Expected to Grow: Should You Buy?

Zacks

5 months ago

Illumina (ILMN) Earnings Expected to Grow: Should You Buy?

Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development

PR Newswire

5 months ago

Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development

Even after rising 3.7% this past week, Illumina (NASDAQ:ILMN) shareholders are still down 74% over the past five years

Simply Wall St.

5 months ago

Even after rising 3.7% this past week, Illumina (NASDAQ:ILMN) shareholders are still down 74% over the past five years

Should You Hold Illumina (ILMN)?

Insider Monkey

6 months ago

Should You Hold Illumina (ILMN)?

This Cancer Test Could Become Routine—and a Big Seller, Says Analyst

Barrons.com

6 months ago

This Cancer Test Could Become Routine—and a Big Seller, Says Analyst

Illumina, Inc. (ILMN): Among Recent Activist Investor Campaigns

Insider Monkey

6 months ago

Illumina, Inc. (ILMN): Among Recent Activist Investor Campaigns

Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks

StockStory

6 months ago

Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks

Illumina, Tempus AI partner to drive genomic testing beyond cancer

MedTech Dive

6 months ago

Illumina, Tempus AI partner to drive genomic testing beyond cancer

MT Newswires

6 months ago

Illumina, Tempus AI Collaborating to Accelerate Clinical Use of Sequencing Tests

Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation

PR Newswire

6 months ago

Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation

Share on Social Networks: